Pill-in-the-POCKET Oral Anticoagulation Strategy After AF Catheter Ablation
Status:
RECRUITING
Trial end date:
2030-12-31
Target enrollment:
Participant gender:
Summary
The clinical benefit of pill-in-the-POCKET anticoagulation after atrial fibrillation catheter ablation remains uncertain. We aimed to evaluate the clinical benefit and safety of pill-in-the-POCKET anticoagulation after atrial fibrillation catheter ablation by randomizing into two groups: non-interrupted anticoagulation after the procedure and anticoagulation based on atrial fibrillation recurrence confirmed by implantable loop recorders.
Phase:
NA
Details
Lead Sponsor:
Seoul National University Hospital
Collaborators:
Medtronic Korea Co., Ltd. Samjin Pharmaceutical Co., Ltd.